Skip to main content

Table 1 Characteristics of included studies

From: Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects

Author

Year

Country

Ethnicity

Source

Genotyping method

Cancer type

Total number

Cases

Controls

HWE of controls

Cases

Controls

Lys/Lys

Lys/Gln

Gln/Gln

Lys/Lys

Lys/Gln

Gln/Gln

 

Sturgis [26]

2000

America

Caucasian

HB

PCR-RFLP

SCCHN

189

496

75

83

31

218

221

57

0.9304

Gajecka [21]

2005

Poland

Caucasian

HB

PCR-RFLP

LC

293

320

110

135

48

87

175

58

0.0659

Huang [23]

2005

America

Caucasian

Mix*

TaqMan-PCR

HNC

425

683

176

188

61

296

292

95

0.0951

Rydzanicz [24]

2005

Poland

Caucasian

HB

PCR-RFLP

HNC

172

143

69

73

30

54

64

25

0.4265

Kietthubthew [32]

2006

Thailand

Asian

PB

PCR-RFLP

SCCOC

105

164

83

21

1

126

36

2

0.7489

Matullo [25]

2006

Europe

Caucasian

nest

TaqMan-PCR

UADC

82

1094

34

39

9

397

504

193

0.1330

Ramachandran [37]

2006

India

Asian

HB

PCR-RFLP

OC

110

110

49

46

15

71

31

8

0.0908

An [22]

2007

America

Caucasian

HB

PCR-RFLP

SCCHN

829

854

330

394

105

358

386

110

0.7091

Bau [27]

2007

Taiwan

Asian

HB

PCR-RFLP

OC

154

105

134

18

2

89

15

1

0.6824

Yang [29]

2007

China

Asian

PB

PCR-RFLP

NPC

153

168

128

24

1

124

43

1

0.1805

Majumder [31]

2007

India

Asian

HB

PCR-RFLP

OC

309

388

158

125

26

190

158

40

0.4030

Harth [35]

2008

Germany

Caucasian

HB

PCR-RFLP

SCCHN

312

300

111

154

47

108

149

43

0.4642

Mitra [34]

2009

North India

Caucasian

HB

PCR-RFLP

SCCHN

275

385

88

148

39

163

179

43

0.5571

Jelonek [33]

2010

Poland

Caucasian

HB

PCR-RFLP

HNC

103

110

29

52

22

38

60

12

0.1030

Ji [28]

2010

Korea

Asian

HB

PCR-SBE

SCCHN

267

348

232

32

3

298

48

2

0.9645

Stembalska [38]

2011

Poland

Caucasian

HB

PCR-RFLP

LSCC

60

100

20

26

14

32

46

22

0.4795

Kumar [36]

2012

North India

Caucasian

HB

PCR-RFLP

SCCHN

278

278

92

125

61

129

110

39

0.0531

Yuan [30]

2012

China

Asian

PB

TaqMan-PCR

HNC

394

887

333

57

4

752

129

6

0.8556

  1. HB hospital-based study, PB population-based study, *two population-based studies and one hospital-based study, nest nested case–control study, PCR-RFLP polymerase chain reaction-restriction fragment length polymorphism, PCR-SBE polymerase chain reaction-single base extension, HNC head and neck cancer, SCCHN squamous cell cancer of the head and neck, NPC nasopharyngeal cancer, LC laryngeal cancer, LSCC laryngeal squamous cell cancer, UADC upper aerodigestive tract cancer, OC oral cance, HWE Hardy–Weinberg equilibrium.